Abstract
All retinoblastomas (RBs) show genomic changes in addition to loss of both RB1 alleles. Quantitative-multiplex PCR analysis identified in 41 of 70 (59%) RBs a 0.6-Mb minimal region of chromosome 6p22 gain from which we cloned the human kinesin gene, RBKIN/KIF13A, by rapid amplification of retinal cDNA. RBKIN is expressed ubiquitously in adult tissues, at low levels in fetal tissues, and at high levels in RB. Antisense RBKIN oligonucleotide reduced the growth rate of RB cell lines. RBKIN and/or another closely linked gene are candidate oncogenes contributing to malignant progression of RB.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cell Division / drug effects
-
Cell Division / genetics
-
Chromosomes, Human, Pair 6 / genetics*
-
Cloning, Molecular
-
DNA, Complementary / genetics
-
DNA, Neoplasm / genetics
-
Female
-
Gene Amplification
-
Gene Expression
-
Humans
-
Kinesins / biosynthesis
-
Kinesins / genetics*
-
Male
-
Oligonucleotides, Antisense / genetics
-
Oligonucleotides, Antisense / pharmacology
-
Oncogenes / genetics*
-
Retinoblastoma / genetics*
-
Retinoblastoma / metabolism
-
Reverse Transcriptase Polymerase Chain Reaction
Substances
-
DNA, Complementary
-
DNA, Neoplasm
-
Oligonucleotides, Antisense
-
Kinesins